Form 4: Hologic Director Martin D. Madaus Reports Acquisition of Stock and Stock Options
SEC Form 4 Filing
Director Martin D. Madaus reports acquisition of common stock and stock options in Hologic Inc.
Summary
- On February 26, 2025, Martin D. Madaus, a director of Hologic Inc., acquired 1,864 shares of common stock.
- These shares were obtained through the vesting of restricted stock units (RSUs) which will be settled in common stock.
- Madaus also acquired 5,535 non-qualified stock options with an exercise price of $64.36, exercisable starting on the date of the 2026 Annual Meeting of Stockholders and expiring on February 26, 2035.
- Following these transactions, Madaus directly owns 2,206 shares of common stock and 5,535 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions by a company director. The acquisition of shares and options could be interpreted as a slightly positive sign of confidence, but it's primarily an informational document.
Positives
- The acquisition of shares and stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting of RSUs and granting of stock options suggest an ongoing equity-based compensation plan.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions of key personnel.
Stakeholder Impact
- The transactions reported may have a minor positive impact on shareholder sentiment, as they reflect insider confidence.
Key Dates
| Date | Description |
|---|---|
| 02/26/2025 | Date of transaction: Acquisition of common stock and stock options. |
| 02/26/2025 | Date options become exercisable: Options become exercisable on the date of the 2026 Annual Meeting of Stockholders. |
| 02/26/2035 | Expiration date of the non-qualified stock options. |
| 02/28/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.